Subtopic Deep Dive
Tripterygium wilfordii in Autoimmune Diseases
Research Guide
What is Tripterygium wilfordii in Autoimmune Diseases?
Tripterygium wilfordii extracts, including triptolide and celastrol, suppress autoimmune diseases through anti-inflammatory and immunosuppressive mechanisms targeting NF-κB and JAK/STAT pathways.
Tripterygium wilfordii Hook F, known as Thunder God Vine, yields active compounds like triptolide and celastrol used in traditional Chinese medicine for rheumatoid arthritis and psoriasis. Clinical studies show efficacy in reducing inflammation in conditions like membranous glomerulonephritis and colitis. Over 10 papers from 1997-2018 report 100-300 citations each on its mechanisms and trials.
Why It Matters
Tripterygium wilfordii compounds offer alternatives to synthetic immunosuppressants in rheumatoid arthritis, with Lipsky and Tao (1997) demonstrating efficacy comparable to methotrexate in trials. Celastrol modulates T cell balance in autoimmune inflammation, as shown by Astry et al. (2015) in target organs. Triptolide treats psoriasis and lupus by inhibiting immune-mediated responses (Han et al., 2012), addressing gaps in long-term safety of biologics.
Key Research Challenges
Toxicity and Safety Profiling
Triptolide and celastrol cause hepatotoxicity and reproductive toxicity, limiting clinical use. Chen (2001) notes dose-dependent side effects in early trials. Long-term safety data remains scarce (Tao and Lipsky, 2000).
Optimal Dosing Regimens
Variable bioavailability complicates standardization across patients. Zhou et al. (2016) highlight inconsistent dosing in glomerulonephritis models. Clinical translation requires pharmacokinetic studies (Chen et al., 2018).
Mechanism Specificity
Broad immunosuppression risks infections without targeting specific autoimmune pathways. Wang et al. (2009) show JAK/STAT downregulation but off-target effects persist. Selective modulation challenges persist (Cascão et al., 2017).
Essential Papers
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
Shaoru Chen, Yan Dai, J. Zhao et al. · 2018 · Frontiers in Pharmacology · 323 citations
Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant <i>Tripterygium wilfordii</i> Hook F. These compounds exhibit similar pharmacological activities...
Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook F
Benny J. Chen · 2001 · Leukemia & lymphoma/Leukemia and lymphoma · 302 citations
Triptolide is a diterpenoid triepoxide purified from a Chinese herb Tripterygium Wilfordii Hook F (TWHF). TWHF has been used in traditional Chinese medicine for more than two thousand years. Howeve...
THE CHINESE ANTI-INFLAMMATORY AND IMMUNOSUPPRESSIVE HERBAL REMEDY TRIPTERYGIUM WILFORDII HOOK F
Xuelian Tao, Peter E. Lipsky · 2000 · Rheumatic Disease Clinics of North America · 288 citations
Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases
Rita Cascão, João Eurico Fonseca, Luís F. Moita · 2017 · Frontiers in Medicine · 236 citations
The identification of new bioactive compounds derived from medicinal plants with significant therapeutic properties has attracted considerable interest in recent years. Such is the case of the <i>T...
Triptolide in the treatment of psoriasis and other immune‐mediated inflammatory diseases
Rui Han, Martin Rostami‐Yazdi, Sascha Gerdes et al. · 2012 · British Journal of Clinical Pharmacology · 153 citations
Apart from cancer chronic (auto)immune‐mediated diseases are a major threat for patients and a challenge for physicians. These conditions include classic autoimmune diseases like systemic lupus ery...
Triptolide Attenuates Inflammatory Response in Membranous Glomerulo-Nephritis Rat via Downregulation of NF-&#x03BA;B Signaling Pathway
Ying Zhou, Yan Hong, Haihua Huang · 2016 · Kidney & Blood Pressure Research · 151 citations
<b><i>Background/Aims: </i></b>Triptolide (TPL), a main active ingredient of <i>Tripterygium wilfordii</i> has been shown to exert anti-inflammatory effect. The ...
Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells
Mi Jin Yoon, A Reum Lee, Soo Ah Jeong et al. · 2014 · Oncotarget · 139 citations
Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine", is known to have anticancer activity, but its underlying mechanism is not completely understood. In this study, we show tha...
Reading Guide
Foundational Papers
Start with Chen (2001, 302 citations) for triptolide basics and Tao/Lipsky (2000, 288 citations) for clinical overview, as they establish immunosuppressive foundations. Lipsky/Tao (1997, 139 citations) details rheumatoid arthritis trials.
Recent Advances
Chen et al. (2018, 323 citations) mechanistically reviews triptolide/celastrol; Astry et al. (2015, 126 citations) shows celastrol's T cell effects; Cascão et al. (2017, 236 citations) expands chronic disease applications.
Core Methods
NF-κB/JAK-STAT inhibition via triptolide (Wang et al., 2009); T cell modulation by celastrol (Astry et al., 2015); dose-response in rat models (Zhou et al., 2016).
How PapersFlow Helps You Research Tripterygium wilfordii in Autoimmune Diseases
Discover & Search
PapersFlow's Research Agent uses searchPapers and exaSearch to find Tripterygium wilfordii trials, revealing Chen et al. (2018) as a top-cited mechanistic review with 323 citations. citationGraph traces influence from foundational works like Chen (2001, 302 citations) to recent applications. findSimilarPapers expands to related autoimmune studies.
Analyze & Verify
Analysis Agent employs readPaperContent on Tao and Lipsky (2000) to extract trial data, then verifyResponse with CoVe checks claims against 250M+ OpenAlex papers. runPythonAnalysis processes dose-response curves from Zhou et al. (2016) using pandas for IC50 statistics. GRADE grading scores evidence as moderate for rheumatoid arthritis efficacy.
Synthesize & Write
Synthesis Agent detects gaps in long-term toxicity studies across papers like Lipsky and Tao (1997). Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10+ papers, with latexCompile generating formatted manuscripts. exportMermaid visualizes NF-κB pathway inhibitions from Chen et al. (2018).
Use Cases
"Analyze triptolide dosing safety in rheumatoid arthritis trials"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of doses from Lipsky/Tao 1997, Chen 2001) → statistical summary of toxicity rates.
"Draft LaTeX review on celastrol for autoimmune T cell modulation"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Astry 2015, Cascão 2017) → latexCompile → PDF with cited mechanisms.
"Find code for Tripterygium compound simulations"
Research Agent → paperExtractUrls (Wang 2009) → Code Discovery → paperFindGithubRepo → githubRepoInspect → NF-κB simulation scripts.
Automated Workflows
Deep Research workflow scans 50+ papers on Tripterygium wilfordii, chaining searchPapers → citationGraph → structured report on autoimmune efficacy with GRADE scores. DeepScan applies 7-step analysis to Chen et al. (2018), verifying mechanisms via CoVe and runPythonAnalysis on pathway data. Theorizer generates hypotheses on triptolide-celastrol synergies from Han et al. (2012) and Astry et al. (2015).
Frequently Asked Questions
What defines Tripterygium wilfordii's role in autoimmune diseases?
Extracts like triptolide and celastrol from Tripterygium wilfordii Hook F provide immunosuppression via NF-κB inhibition for rheumatoid arthritis and psoriasis (Chen et al., 2018; Chen, 2001).
What are main methods studied?
In vitro NF-κB downregulation and in vivo rat models of glomerulonephritis assess efficacy (Zhou et al., 2016; Wang et al., 2009). Clinical trials compare to methotrexate (Lipsky and Tao, 1997).
What are key papers?
Chen (2001, 302 citations) introduces triptolide; Tao and Lipsky (2000, 288 citations) review herbal remedy; Chen et al. (2018, 323 citations) overviews mechanisms.
What open problems exist?
Toxicity limits dosing; selective pathway targeting needed; long-term human trials lacking (Cascão et al., 2017; Astry et al., 2015).
Research Natural Compounds in Disease Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Tripterygium wilfordii in Autoimmune Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers